Bill
SB 432
TO AMEND THE LAW CONCERNING ACCOUNTANTS; AND TO AMEND THE DEFINITION OF SUBSTANTIAL EQUIVALENCY FOR THE PRACTICE OF ACCOUNTANCY.
2025 Regular Session
Introduced by Jim Petty and 1 co-sponsor
SB 432 classifies 7-Hydroxymitragynine as a Schedule I drug and imposes strict penalties for xylazine trafficking, enhancing Florida's controlled substances regulations.
Notification that SB432 is now Act 428